Of note, this reduced capacity of leukemic cells to stimulate iNKT cells can be effectively reversed by retinoic acid, which upregulates the expression of CD1d on CLL cells and enhances iNKT-mediated cytotoxicity against tumor targets loaded with α-galactosylceramide (59). Here, CD1D is linked to B-cell chronic lymphocytic leukemia.